Full list of CLAD free pdf questions updated today

Killexams.com offers a person to download 100% totally free CLAD mock exam to test prior to you registering regarding full copy. Check our CLAD examination sim which will enable you to encounter the real CLAD Exam Cram. Passing the actual CLAD examination will become a lot simple for you. killexams.com allows you three or more months free up-dates of CLAD Certified LabVIEW Associate Developer (CLAD) examination queries.

Exam Code: CLAD Practice exam 2023 by Killexams.com team
CLAD Certified LabVIEW Associate Developer (CLAD)

The best preparation for this exam is LabVIEW programming experience applying the concepts presented in LabVIEW Core1 and Core2 courses. Class attendance alone will not be sufficient. Typical CLAD candidates have taken NIs LabVIEW Core 1 and Core 2 courses (or equivalent) and have at least 6 to 9 months of experience using LabVIEW.

This prep guide provides an overview of the exam, including exam logistics and coverage. The relevant knowledge, skills and abilities (KSAs) tested by the CLAD exam are listed in the KSAs: Knowledge, Skills and Abilities tested by the CLAD section. A detailed Topic List table follows the KSA descriptions.

This prep guide also includes example questions. This is not a demo exam. The questions are included as a study aid. They reflect the scope of the CLAD exam and familiarize the test-taker with NIs approach to testing the KSAs relevant to a Certified LabVIEW Associate Developer.

Scoring

A score of 70% or higher is required to pass the exam.



Individuals may take the CLAD exam at any PearsonVUE testing center by scheduling the exam at http://www.pearsonvue.com/ni/. When you schedule the exam, be sure to specify whether you wish to take the exam using LabVIEW NXG or LabVIEW 20xx (where xx indicates current year). The images and terminology of the exam will reflect the LabVIEW editor you choose, but the exam content will otherwise be identical. Simply choose the LabVIEW editor with which you are most comfortable.

Passing the CLAD exam using either editor earns the same CLAD Certification.

You cannot use LabVIEW or any other resources during the exam. The CLAD exam provides screenshots from the LabVIEW environment and LabVIEW Help where appropriate. Refer to the Example Questions & Resources section for examples.

To take the exam, you must agree to a Non-Disclosure Agreement (NDA). The NDA states that you will not copy, reproduce, or communicate any section of the exam in any form, including verbal or electronic. Failure to comply with the NDA will result in penalties ranging from a failed exam to a lifetime ban from LabVIEW Certification



The CLAD exam centers around jobs requiring programming in professional settings, including Automated Test, High-Channel-Count Data Acquisition, or Domain Support. Most of these jobs include collecting and/or processing data in the form of signals from sensors. To verify the relevant knowledge, skills and abilities, the CLAD uses an NI-DAQmx system as representative hardware. NI-DAQmx was chosen because it can be simulated on all versions of LabVIEW. If you have access to LabVIEW, you have the resources to prepare for the exam. You do not need to purchase specific hardware.

Appendix I of the document provides instructions for setting up simulated hardware sufficient for exam preparation. The appendix also includes a list of the DAQmx functions possibly used in the exam. The exam does not test DAQmx function-specific settings. The questions use NI-DAQmx to test knowledge and skills necessary for common data acquisition tasks, such as calculating demo rates, determining the correct order of operations, and programming basic file I/O.

A person using LabVIEW at the Associated Developer level will be able to:

• Use software architectures from a single VI to a simple State Machine or Event-Driven UI

Handler.

• Collect data from sensors using NI Hardware.

• Use Array functions extensively to extract and manipulate a single channel of data from multiple-channel data represented by a 1D waveform array or a 2D numeric array.

• Use loops to run a test a set number of times or until a condition is met, to establish a voltage ramp, or conduct other repeated tasks.

• Create and modify SubVIs, clusters, and Type Defs to simplify their code and contribute to larger projects.



Hardware (10% of exam questions)

• Connecting Hardware: Sensors, DAQ, Devices under test (DUT.

• Acquiring and validating a signal

• Processing signals

• Using appropriate demo rates

LabVIEW Programming Environment (25% of exam questions)

• Setting up and using a LabVIEW Project to:

o Add, delete, and move elements

o Use libraries and appropriate types of folders

o Avoid cross-linking

• Data Types:

o Recognize data types on the front panel

o Recognize data types on the block diagram from terminals and wires

o Choose appropriate controls, indicators, data types, & functions for a given scenario

• Predicting order-of-execution and behavior of

o A non-looping VI

o A Simple State Machine

o An Event-driven UI Handler

o Parallel Loops (without queues)

• Using basic functions to create a simple Acquire-Analyze-Visualize application

• Troubleshooting by identifying and correcting the cause of a broken arrow or incorrect data

• Error handling using error clusters and merge error functions to ensure errors are handled well

• Navigating LabVIEW help to get more information about inputs, outputs, and functions

LabVIEW Programming Fundamentals (50% of exam questions)

• Loops

o Create continuous HW acquisition or generation loop by applying a

Open-Configure-Perform Operation-Close model.

o Retain data in shift registers

o Use input and output terminals effectively, including:

▪ Determining the last value output

▪ Indexing input and output terminals

▪ Concatenating output

▪ Using conditional output

▪ Using shift registers, both initialized and uninitialized.

o Use timing of loops appropriately, including:

▪ Software timing

▪ Hardware timing

o Use For Loops and While Loops appropriately



Arrays

o View data from an n-channel HW acquisition VI (using the DAQmx Read VI) using a

waveform graph, waveform chart, or numeric/waveform array indicator.

o Extract a single channel of data (waveform or 1D Array) from a:

▪ 1D waveform array representing acquired data from multiple channels

▪ 2D numeric array representing acquired data from multiple channels

▪ 1D numeric array representing single measurement from multiple channels

o Use a For Loop with auto-indexing and conditional tunnels to:

▪ Iterate through an array

▪ Iterate processing code on each channel of data in a 1D waveform array

▪ Generate an array of data that meets required conditions

o Identify by sight and be able to use and predict the behavior of the following array

functions and VIs:

▪ Array Size

▪ Index Array

▪ Replace Subset

▪ Insert Into Array

▪ Delete From Array

▪ Initialize Array

▪ Build Array

▪ Array Subset

▪ Max & Min

▪ Sort 1D Array

▪ Search 1D Array

▪ Split 1D Array

• Writing conditional code to perform an action based on the value of a user input or a measurement result.

• memorizing and Writing data to a file

o Use Open/Act/Close model for file I/O

o Write data to a text file using high-level file I/O functions

o Continuously stream data to a text file or a TDMS file

o Append data to an existing data file

o Log data using simple VIs



Acquire data from DAQmx functions

o Display data on a graph

o Save data to a CSV file

o Choose single measurement/multiple channel and single channel/multiple

measurements configurations appropriately

Programming Best Practices (15% of exam questions)

• SubVIs – Reusing Code

o Create SubVIs to increase readability and scalability of VIs

o Configure the subVI connector pane using best practices

o Choose appropriate code as a SubVI source

• Clusters – Grouping Data of Mixed Data Types

o Create, manipulate, analyze, and use cluster data in common scenarios

o Group related data by creating a cluster to Excellerate data organization and VI readability

• Type Defs – Propagate Data Type Changes

o Create Type Defs and use Type Defs in multiple places

o Update Type Defs to propagate changes to all instances of the Type Def


Certified LabVIEW Associate Developer (CLAD)
NI Certified test
Killexams : NI Certified test - BingNews https://killexams.com/pass4sure/exam-detail/CLAD Search results Killexams : NI Certified test - BingNews https://killexams.com/pass4sure/exam-detail/CLAD https://killexams.com/exam_list/NI Killexams : NI Announces New LabVIEW Features to Turn Test Performance into Business Performance No result found, try new keyword!AUSTIN, Texas--(BUSINESS WIRE)--NI, formerly known as National Instruments, today announced a significant upgrade to its flagship product LabVIEW. For nearly 40 years, LabVIEW has been the ... Wed, 26 Jul 2023 23:06:00 -0500 https://www.businesswire.com/news/home/20230727693038/en/NI-Announces-New-LabVIEW-Features-to-Turn-Test-Performance-into-Business-Performance/ Killexams : Learn LabView to win NI Test Workflow software and equipment Killexams : Learn LabView to win NI Test Workflow software and equipment Tue, 15 Aug 2023 02:38:00 -0500 Caroline Hayes en-GB text/html https://www.electronicsweekly.com/news/products/test-measurement-products/learn-labview-to-win-ni-test-workflow-software-and-equipment-2023-08/ Killexams : National Instruments Returns to Its Roots with LabView NXG

In one of its biggest rollouts in years, National Instruments (NI) said it is returning to its roots and introducing a simple test and measurement product that’s aimed at capturing engineer customers who aren’t programmers.

Known as LabView NXG 1.0, the new product builds on the founders’ original vision of creating an approachable, graphical environment for users. It comes 31 years after the introduction of the test and measurement giant’s flagship product, called LabView. “The target customer of LabView NXG is the one who looked at LabView in the last few years and said, ‘That’s just too hard,’” Jeff Phillips, technical program lead for National Instruments, told Design News.

At NIWeek, National Instruments rolled out a simpler, more approachable edition of LabView, called LabView NXG. (Source: National Instruments)

With LabView NXG, National Instruments plans to address that issue with a heavy dose of graphical visualization. “You can see the hardware being visualized in the product – not just as a node with a reference number but as a box that looks like the hardware, sitting on a table, with documentation and annotation,” Phillips said. “Everywhere throughout Labview NXG, you can see data on a graph, and you can right click and capture that data into a data pane that stores it in your project.”

With the intro of the new product, the company is also focusing on interactive workflow and the concept of graphical programming. “We’ve worked extremely hard to maintain the semantics of graphical programming while improving the user experience along the way,” Phillips added.

For NI, the rollout of LabView NXG is a bit of deva vu. The company originally introduced LabView in 1986, with the idea of giving “spreadsheet-type simplicity” to the complex world of test and measurement. LabView ultimately grew into the foundation of NI, which now does about $1.2 billion in business annually. Millions of people, ranging from engineers and technicians to college students and even high school students, have used LabView over the decades. NI still has hundreds of thousands of industrial users on its active service contracts, and many more in the academic arena, it said.

The LabView product has evolved over the years, however, shifting slightly away from its original vision. Starting in about 2003, it took a turn toward the embedded market and added features for those users. But while that expanded the product’s reach and boosted its appeal for throngs of new users, some of LabView’s well-known simplicity was lost. “The approachability of the product for new users became an afterthought,” Phillips recalled. “And we really started to feel the burden with those new users. We saw our success rate with them start to decline.”

Phillips said that the intent of NXG is to re-capture that spirit among the new user community. It is expected to be popular, as it always has been, among engineers developing medical products and white goods, as well as those doing R&D testing. “The focus of LabView NXG is on the people who need to program, not on programmers,” he said.

The company continues to offer the current version of LabView, as well, separately from the new NXG product.

On stage at NIWeek, NI demonstrated LabView NXG by quickly measuring the pressure wave off a cowboy’s bullwhip. (Source: Design News)

NI announced LabView NXG this week at NIWeek, an annual event taking place in Austin, TX. As if to put an exclamation on the rollout, NI did a demonstration with a real-life San Antonio cowboy, using LabView NXG along with a PXIe 4480 sound and vibration module to quickly and simply analyze the pressure wave off the cowboy’s bullwhip, while approximately 3,000 engineers looked on.

In a separate session, Jeff Kodosky, company co-founder and “father of LabView,” talked about the original “spreadsheet” vision and the subsequent evolution of the technology. “We marketed LabView as the non-programming way to automate measurements,” he said.

This week, NI engineers said the analogy is still relevant, even though the current technology bears no similarity to the spreadsheet. “The metaphor of the spreadsheet is still the foundation of what we’re trying to do with LabView NXG,” Phillips said.  

Senior technical editor Chuck Murray has been writing about technology for 33 years. He joined Design News in 1987, and has covered electronics, automation, fluid power, and autos.

Tue, 08 Aug 2023 12:00:00 -0500 en text/html https://www.designnews.com/electronics-test/national-instruments-returns-its-roots-labview-nxg
Killexams : High blood sugar may raise heart disease risk even if you don’t have diabetes
  • Researchers found that people with elevated blood sugar levels have a 30–50% increased risk of developing heart disease, even if their blood sugar levels are below the threshold for diabetes.
  • The findings show that males were more likely to be prescribed preventive antihypertensive and statin therapies than females, revealing a “prescribing gap.”
  • Healthy blood sugar levels are important for health and energy, and certain factors may spike blood sugar, even when a person does not have diabetes.

Every person needs a certain amount of sugar in their blood to stay healthy and energized.

A person’s blood sugar levels will fluctuate throughout the day depending on what they eat and is also impacted by their age and overall health.

Researchers from the London School of Hygiene & Tropical Medicine and University College London have found both men and women with raised blood sugar levels have a 30–50% increased risk for developing cardiovascular disease, even if their blood sugar levels are below the threshold for diabetes.

Additionally, researchers reported a potential disparity between the amount of preventive antihypertensive and statin medications prescribed to males and females, suggesting a potential “prescribing gap.”

This study was recently published in the journal The Lancet Regional Health – Europe.

Researchers analyzed data from the UK Biobank of more than 427,000 UK residents for the study.

About 54% of participants were females and about 46% were males. All participants had different blood sugar levels including:

  • healthy
  • prediabetic
  • diabetic

Dr. Christopher Rentsch, PhD, assistant professor of epidemiology at the London School of Hygiene & Tropical Medicine and lead author of this study explained to Medical News Today:

“We were interested to explore which risk factors drive known sex differences in the risk of heart disease between men and women with diabetes, and whether men or women with moderately elevated blood sugar below the threshold for diabetes are also at increased risk of heart disease.”

Upon analysis and after adjusting for age, the research team found both men and women with moderately elevated blood sugar levels below the threshold for diabetes were at increased risk for any type of cardiovascular disease.

“The finding that moderately elevated blood sugar below the diabetes threshold was associated with (an) increased risk of heart disease was not entirely surprising based on prior research in this area. For example, there is a recognized state of ‘prediabetes’ where blood sugar is elevated but not yet meeting the criteria for a diabetes diagnosis. Prediabetes is known to increase the risk of progressing to diabetes and potentially developing heart disease. Key novel contributions of our work were quantifying the risk of heart disease across a full range of blood sugar levels for both men and women and demonstrating these associations were largely explained by modifiable factors.”

Dr. Christopher Rentsch, PhD, lead study author

Dr. Rentsch and his team also found a difference in risk levels between men and women.

Scientists found men with increased blood sugar levels below the threshold for diabetes had a 30% greater risk of developing cardiovascular disease. However, women with the same levels had a great risk of between 30–50%.

“Our study represents a meaningful step forward from decades of research on the link between diabetes and heart disease, which has long asserted that men and women with diabetes have differential risks of heart disease,” Dr. Rentsch said.

“Therefore, while robust quantification was still needed, the notion that moderately elevated blood sugar levels could be associated with greater risks of heart disease in women versus men was plausible based on existing scientific literature.”

“Our work strengthens the evidence by rigorously quantifying the higher relative risks in women across the full range of blood sugar levels,” he continued.

“Importantly, we discovered that differences between men and women in the risk of developing heart disease largely disappeared after we accounted for, in particular, measures of obesity and the use (of) preventative medications like antihypertensive and statin therapies.”

After reviewing this study, Dr. Nate Lebowitz, an attending cardiologist specializing in cholesterol and preventive cardiology care at Hackensack University Medical Center told MNT he was not surprised by its results.

Still, Dr. Lebowitz noted the findings convey an “important message” that the higher end of healthy — or otherwise minimally elevated — glucose levels were a marker for insulin resistance, which is why these people had a higher risk of heart disease.

“When it comes to diabetes and prediabetes, the risk of cardiovascular disease is not so much related to elevated glucose as it is to insulin resistance, which can be genetically determined, or related to excess body weight, a sedentary lifestyle, poor diet and often a combination of these factors. Insulin resistance is present in the earliest stages of prediabetes when glucose is still normal, or minimally elevated. (And) insulin resistance confers an elevated risk of cardiovascular disease (as) this study confirmed a higher risk in these patients.”

— Dr. Nate Lebowitz, cardiologist

And Dr. Yu-Ming Ni, a board-certified cardiologist and lipidologist at MemorialCare Heart and Vascular Institute at Orange Coast Medical Center in Fountain Valley, CA, agreed and provided more insight into how insulin resistance affects the cardiovascular system.

“Insulin resistance is where our body makes insulin but our tissues don’t really listen to it,” he explained. “As a result, blood sugar levels increase in the blood. It can cause the lining of the blood vessels to become damaged and so you can have more likelihood for plaque build-up on the lining of the walls of the blood vessels that can then lead to heart disease.”

“And we know that’s the case because patients with diabetes tend to have multiple blood vessel involvements,” Dr. Ni added. “When we do an angiogram, if you look at the arteries of the heart, we tend to see they have multiple blood vessels that are involved because of the long-standing exposure to damaging blood sugar.”

And the study researchers also reported a disparity between men and women when it came to receiving preventative medications.

Dr. Rentsch and his team found more men than women were on preventative antihypertensive and statin medications, suggesting a “prescribing gap” between men and women with similar blood sugar levels.

“Our findings support women being proactive in asking about medications like statins and antihypertensives as an option to help lower their risk if clinically appropriate,” Dr. Rentsch said.

“The decision to initiate preventive medications requires carefully weighing individual risks, benefits, and preferences. But this study provides backing for women to open a dialogue with their provider about whether preventive medications may be a suitable part of their overall cardiovascular risk reduction plan.”

Dr. Lebowitz commented this finding illustrates that, even to this day, women are not treated as well, as aggressively, or properly compared to men when it comes to identifying and preventing cardiovascular disease.

“The treatment of heart disease, hypertension, cholesterol, and diabetes is supposedly getting better for women, but there is still a disparity in care. This disparity is putting women at higher risk. This study proves that when these risk factors are addressed equally in both sexes — the risk factors related to glucose and insulin resistance — it makes a significant difference in outcomes. Doctors need to realize that women are at similar risk just as much as men.”

— Dr. Nate Lebowitz, cardiologist

Sometimes a person’s blood sugar, also known as blood glucose, can become too high. Certain factors may cause a person’s blood sugar to spike, even if they do not have diabetes. These may include:

There are a few different tests used to determine a person’s blood sugar levels.

One of those tests is the fasting blood sugar test, where a person’s levels are checked when they have not eaten. A fasting glucose memorizing of 99 mg/dL or below is considered healthy.

Another commonly used test is the A1C test, which measures a person’s average blood sugar levels over two to three months. An A1C test memorizing of 5.7% or below is considered healthy.

When a person’s blood sugar levels test in ranges above normal, it is considered high blood sugar, medically known as hyperglycemia. High blood sugar can signal either prediabetes or diabetes.

Symptoms of high blood sugar include:

If left untreated, high blood sugar levels can lead to a variety of health issues, including:

Previous research has also linked high blood sugar levels to an increased risk for certain heart conditions, including stroke and high blood pressure. Talk with your doctor if you’re concerned about your blood sugar levels and heart disease risk.

Fri, 11 Aug 2023 07:12:00 -0500 en text/html https://www.medicalnewstoday.com/articles/high-blood-sugar-heart-disease-risk
Killexams : Bird flu: Wild mammals test positive for first time in NI

Avian influenza has been detected in two fox cubs in Portrush, the first time the virus has been found in wild mammals in Northern Ireland.

Stormont's Department of Agriculture, Environment and Rural Affairs (DAERA) said the development "is not unexpected".

It added it has continued to confirm positive cases in wild birds.

The results were confirmed following routine disease surveillance, DAERA added.

Laboratory results confirmed the strain to be H5N1.

The Public Health Agency has said human infections with the disease are rare.

It is believed wild mammals can become infected after eating dead or sick wild birds.

BirdWatch Ireland said the highly pathogenic H5N1 strain of the virus is devastating key Irish seabird colonies.

Belfast's Window on Wildlife nature reserve was closed to the public last month after a number of gulls were found to have died from the virus.

Members of the public have been urged to report any findings of dead wild birds through an online reporting form on the DAERA website.

The department also encouraged the public to keep their dogs on leads and keep pets away from carcasses, particularly in coastal areas.

Fri, 28 Jul 2023 22:53:00 -0500 en-GB text/html https://www.bbc.com/news/uk-northern-ireland-66343489
Killexams : ACME Lithium Successfully Completes 10-Day Pumping Test at Clayton Valley Lithium Brine Project

Carson City, Nevada--(Newsfile Corp. - August 17, 2023) - ACME Lithium Inc. (CSE: ACME) (OTCQX: ACLHF) (the "Company", or "ACME") is pleased to report that the Company has successfully completed a 10-day pumping test at test well TW-1 located in Clayton Valley, Nevada. The data generated during the test will be used to estimate the transmissivity and the storativity of the Lower Gravel Unit (LGU) at the TW-1 location. Preliminary Phase 1 and Phase 2 data suggest the perforated casing of TW-1 captures approximately 500 feet of potential lithium brine aquifer hosted in the LGU. The LGU is the basal gravel overlaying bedrock in Clayton Valley.

Figure 1: Lithium Brine Samples, Clayton Valley Nevada

State permits limited pumping from TW-1 to a maximum rate of 100 gallons per minute (gpm), with total discharge not to exceed 5-acre feet. This permit requirement was strictly adhered to during the test. However, the drawdown measured at a pumping rate of 95 gpm over 10 consecutive days suggests the LGU would sustain significantly higher extraction rates over time, and that TW-1 is in a potential production aquifer in Clayton Valley.

A range of brine samples were collected during the pumping test. These samples were submitted to Nevada certified laboratories for multi-element chemical analyses, to include total and dissolved lithium. Bulk samples were also collected for potential bench-scale testing for Direct Lithium Extraction (DLE) and processing. Preliminary results from the TW-1 pumping test and laboratory analyses are anticipated to be available by end of August 2023.

Intact HQ core recovered from DH-1 was submitted to GeoSystems Analysis Inc. The core was submitted with brine collected from the TW-1 pumping test. The core and brine demo will be used for laboratory testing of drainable porosity (Specific Yield). The results of the laboratory testing of the core samples and the results from the TW-1 pumping test will be used to assess the potential volume of lithium enriched brine and extractability of the brine from the LGU aquifer through pumping. With further evaluation and results pending, the assessment of extractable brine volume and concentration of lithium in the brine will be used to infer if a lithium resource potentially exists at the ACME project.

William Feyerabend, Certified Professional Geologist and Mathew Banta, Certified Professional Hydrogeologist are qualified persons as defined by NI 43-101 and have supervised the preparation of the scientific and technical information that forms the basis for this news release.

About ACME Lithium Inc.

Led by an experienced team, ACME Lithium is a mineral exploration Company focused on acquiring, exploring, and developing battery metal projects in partnership with leading technology and commodity companies. ACME has acquired or is under option to acquire a 100-per-cent interest in projects located in Clayton Valley and Fish Lake Valley, Esmeralda County Nevada, at Shatford, Birse, and Cat-Euclid Lakes in southeastern Manitoba, and at Bailey Lake in northern Saskatchewan.

On behalf of the Board of Directors

Steve Hanson
Chief Executive Officer, President and Director
Telephone: (604) 564-9045
info@acmelithium.com

For Investor Inquiries
Anthony Simone
Simone Capital
Telephone: (416) 818-5154
asimone@simonecapital.ca

Neither the CSE nor its regulations service providers accept responsibility for the adequacy or accuracy of this news release. This news release may contain forward-looking information within the meaning of applicable securities laws ("forward-looking statements"). Forward-looking statements are statements that are not historical facts and are generally, but not always, identified by the words "expects," "plans," "anticipates," "believes," "intends," "estimates," "projects," "potential" and similar expressions, or that events or conditions "will," "would," "may," "could" or "should" occur and in this news release include but are not limited to the attributes of, timing for and expected benefits to be derived from exploration, drilling or development at ACME's project properties. Information inferred from the interpretation of drilling, sampling and other technical results may also be deemed to be forward-looking statements, as it constitutes a prediction of what might be found to be present when and if a project is actually developed. ACME's project location adjacent to or nearby lithium projects does not ensure exploration success or that mineral resources or reserves will be defined on ACME's properties. Exploration, development, and activities conducted by regional companies provide assistance and additional data for exploration work being completed by ACME. These forward-looking statements are subject to a variety of risks and uncertainties which could cause genuine events or results to differ materially from those reflected in the forward-looking statements, including, without limitation: risks related to fluctuations in metal prices; uncertainties related to raising sufficient financing to fund the planned work in a timely manner and on acceptable terms; changes in planned work resulting from weather, logistical, technical or other factors; the possibility that results of work will not fulfill expectations and realize the perceived potential of the Company's properties; risk of accidents, equipment breakdowns and labour disputes or other unanticipated difficulties or interruptions; the possibility of cost overruns or unanticipated expenses in the work program; the risk of environmental contamination or damage resulting from the Company's operations and other risks and uncertainties. Any forward-looking statement speaks only as of the date it is made and, except as may be required by applicable securities laws, the Company disclaims any intent or obligation to update any forward-looking statement, whether as a result of new information, future events or results or otherwise.

To view the source version of this press release, please visit https://www.newsfilecorp.com/release/177491

Thu, 17 Aug 2023 00:30:00 -0500 en-US text/html https://finance.yahoo.com/news/acme-lithium-successfully-completes-10-123000974.html
Killexams : Varenicline nasal spray may Excellerate tear production in dry eye disease

Varenicline nasal spray effectively manages Dry Eye Disease and improves tear production and DED signs.

A recent study evaluating the efficacy of varenicline nasal spray (VNS) versus vehicle/placebo for treating dry eye disease has concluded that VNS use improves Schirmer test scores over 28 days of treatment.

They noted more incidence of cough and throat irritation in the VNS group.

The lead researcher of this study, “The efficacy and safety of varenicline nasal spray for the management of dry eye signs: a systematic review and meta-analysis”, is Dr Bader Bashrahil and is published in BMC Ophthalmology.

It is already known that the leading cause of DED is persistently unstable tear film causing ocular discomfort. This eye condition is treated using tear supplementation. Emerging evidence supports the effectiveness of nicotinic acetylcholine receptor (nAChR) agonists (e.g., varenicline and simpinicline) nasal sprays for managing DED.

In the present study, the team assessed the efficacy and safety of varenicline nasal spray (VNS) for DED treatment using databases like CENTRAL, Medline, and Embase.

The mean change in the anaesthetized STS or Schirmer test score, a measure of basal tear production, from baseline was the efficacy endpoint and serious adverse events (SAEs) and adverse events (AEs) were the safety endpoints.

The main Results of the study could be summarised as follows:

  • A total of 3 RCTs with 1063 participants met the eligibility criteria and had a low risk of bias.
  • On day 28, there was an increase in the mean STS change from baseline.
  • There was no significant difference between VNS and placebo in SAE and ocular AE frequency.
  • They found VNS had a substantial effect on developing nasal cavity-related AEs.

They said that VNS improved efficacy endpoints and increased the frequency of nasal cavity-related AEs like cough and throat irritation.

They noted there were neither SAEs nor ocular AEs.

The study limitations include low numbers, inconsistent pooled results and high heterogeneity.

They mentioned that upcoming studies should focus on comparing its safety and efficacy against currently established management options.

Further reading:

Bashrahil, B., Taher, N., Alzahrani, Z. et al. The efficacy and safety of varenicline nasal spray for the management of dry eye signs: a systematic review and meta-analysis. BMC Ophthalmol 23, 319 (2023). https://doi.org/10.1186/s12886-023-03069-y

Mon, 21 Aug 2023 02:30:00 -0500 en text/html https://medicaldialogues.in/ophthalmology/news/varenicline-nasal-spray-may-improve-tear-production-in-dry-eye-disease-116074
Killexams : The Next Green Revolution Picture of genetic code projected onto a sunflower

The genes of all living things on Earth—including the sunflower, a valuable oil crop—consist of varying sequences of four chemical compounds: adenine, thymine, cytosine, and guanine, abbreviated as A, T, C, and G. By identifying genes and manipulating them, scientists hope to create new crops that will help us face the challenges of global warming and population growth.

Modern supercrops will be a big help.
But agriculture can’t be fixed by biotech alone.

Something is killing Ramadhani Juma’s cassava crop. “Maybe it’s too much water,” he says, fingering clusters of withered yellow leaves on a six-foot-high plant. “Or too much sun.” Juma works a small plot, barely more than an acre, near the town of Bagamoyo, on the Indian Ocean about 40 miles north of Dar es Salaam, Tanzania. On a rainy March morning, trailed by two of his four young sons, he’s talking with a technician from the big city, 28-year-old Deogratius Mark of the Mikocheni Agricultural Research Institute. Mark tells Juma his problem is neither sun nor rain. The real cassava killers, far too small to see, are viruses.

Mark breaks off some wet leaves; a few whiteflies dart away. The pinhead-size flies, he explains, transmit two viruses. One ravages cassava leaves, and a second, called brown streak virus, destroys the starchy, edible root—a catastrophe that usually isn’t discovered until harvest time. Juma is typical of the farmers Mark meets—most have never heard of the viral diseases. “Can you imagine how he’ll feel if I tell him he has to uproot all these plants?” Mark says quietly.

Juma is wearing torn blue shorts and a faded green T-shirt with “Would you like to buy a vowel?” printed on the front. He listens carefully to Mark’s diagnosis. Then he unshoulders his heavy hoe and starts digging. His oldest son, who is ten, nibbles a cassava leaf. Uncovering a cassava root, Juma splits it open with one swing of his hoe. He sighs—the creamy white flesh is streaked with brown, rotting starch.

To save enough of the crop to sell and to feed his family, Juma will have to harvest a month early. I ask how important cassava is to him.

“Mihogo ni kila kitu,” he replies in Swahili. “Cassava is everything.”

Most Tanzanians are subsistence farmers. In Africa small family farms grow more than 90 percent of all crops, and cassava is a staple for more than 250 million people. It grows even in marginal soils, and it tolerates heat waves and droughts. It would be the perfect crop for 21st-century Africa—were it not for the whitefly, whose range is expanding as the climate warms. The same viruses that have invaded Juma’s field have already spread throughout East Africa.

Before leaving Bagamoyo, we meet one of Juma’s neighbors, Shija Kagembe. His cassava fields have fared no better. He listens silently as Mark tells him what the viruses have done. “How can you help us?” he asks.

Pictures of wheat, rice, and corn

Click here to launch gallery.

Answering that question will be one of the greatest challenges of this century. Climate change and population growth will make life increasingly precarious for Juma, Kagembe, and other small farmers in the developing world—and for the people they feed. For most of the 20th century humanity managed to stay ahead in the Malthusian race between population growth and food supply. Will we be able to maintain that lead in the 21st century, or will a global catastrophe beset us?

The United Nations forecasts that by 2050 the world’s population will grow by more than two billion people. Half will be born in sub-Saharan Africa, and another 30 percent in South and Southeast Asia. Those regions are also where the effects of climate change—drought, heat waves, extreme weather generally—are expected to hit hardest. Last March the Intergovernmental Panel on Climate Change warned that the world’s food supply is already jeopardized. “In the last 20 years, particularly for rice, wheat, and corn, there has been a slowdown in the growth rate of crop yields,” says Michael Oppenheimer, a climate scientist at Princeton and one of the authors of the IPCC report. “In some areas yields have stopped growing entirely. My personal view is that the breakdown of food systems is the biggest threat of climate change.”

Half a century ago disaster loomed just as ominously. Speaking about global hunger at a meeting of the Ford Foundation in 1959, one economist said, “At best the world outlook for the decades ahead is grave; at worst it is frightening.” Nine years later Paul Ehrlich’s best seller, The Population Bomb, predicted that famines, especially in India, would kill hundreds of millions in the 1970s and 1980s.

Before those grim visions could come to pass, the green revolution transformed global agriculture, especially wheat and rice. Through selective breeding, Norman Borlaug, an American biologist, created a dwarf variety of wheat that put most of its energy into edible kernels rather than long, inedible stems. The result: more grain per acre. Similar work at the International Rice Research Institute (IRRI) in the Philippines dramatically improved the productivity of the grain that feeds nearly half the world.

From the 1960s through the 1990s, yields of rice and wheat in Asia doubled. Even as the continent’s population increased by 60 percent, grain prices fell, the average Asian consumed nearly a third more calories, and the poverty rate was cut in half. When Borlaug won the Nobel Peace Prize in 1970, the citation read, “More than any other person of this age, he helped provide bread for a hungry world.”

To keep doing that between now and 2050, we’ll need another green revolution. There are two competing visions of how it will happen. One is high-tech, with a heavy emphasis on continuing Borlaug’s work of breeding better crops, but with modern genetic techniques. “The next green revolution will supercharge the tools of the old one,” says Robert Fraley, chief technology officer at Monsanto and a winner of the prestigious World Food Prize in 2013. Scientists, he argues, can now identify and manipulate a huge variety of plant genes, for traits like disease resistance and drought tolerance. That’s going to make farming more productive and resilient.

The signature technology of this approach—and the one that has brought both success and controversy to Monsanto—is genetically modified, or GM, crops. First released in the 1990s, they’ve been adopted by 28 countries and planted on 11 percent of the world’s arable land, including half the cropland in the U.S. About 90 percent of the corn, cotton, and soybeans grown in the U.S. are genetically modified. Americans have been eating GM products for nearly two decades. But in Europe and much of Africa, debates over the safety and environmental effects of GM crops have largely blocked their use.

Proponents like Fraley say such crops have prevented billions of dollars in losses in the U.S. alone and have actually benefited the environment. A recent study by the U.S. Department of Agriculture found that pesticide use on corn crops has dropped 90 percent since the introduction of Bt corn, which contains genes from the bacterium Bacillus thuringiensis that help it ward off corn borers and other pests. Reports from China indicate that harmful aphids have decreased—and ladybugs and other beneficial insects have increased—in provinces where GM cotton has been planted.

The particular GM crops Fraley pioneered at Monsanto have been profitable for the company and many farmers, but have not helped sell the cause of high-tech agriculture to the public. Monsanto’s Roundup Ready crops are genetically modified to be immune to the herbicide Roundup, which Monsanto also manufactures. That means farmers can spray the herbicide freely to eliminate weeds without damaging their GM corn, cotton, or soybeans. Their contract with Monsanto does not allow them to save seeds for planting; they must purchase its patented seeds each year.

Though there’s no clear evidence that Roundup or Roundup Ready crops are unsafe, proponents of an alternative vision of agriculture see those expensive GM seeds as a costly input to a broken system. Modern agriculture, they say, already relies too heavily on synthetic fertilizers and pesticides. Not only are they unaffordable for a small farmer like Juma; they pollute land, water, and air. Synthetic fertilizers are manufactured using fossil fuels, and they themselves emit potent greenhouse gases when they’re applied to fields.

“The choice is clear,” says Hans Herren, another World Food Prize laureate and the director of Biovision, a Swiss nonprofit. “We need a farming system that is much more mindful of the landscape and ecological resources. We need to change the paradigm of the green revolution. Heavy-input agriculture has no future—we need something different.” There are ways to deter pests and increase yields, he thinks, that are more suitable for the Jumas of this world.

Pictures of rice agriculture

Click here to launch gallery.

Monsanto is not the only organization that believes modern plant genetics can help feed the world. Late on a warm February afternoon Glenn Gregorio, a plant geneticist at the International Rice Research Institute, shows me the rice that started the green revolution in Asia. We’re in Los Baños, a town about 40 miles southeast of Manila, walking along the edge of some very special rice fields, of which there are many on the institute’s 500 acres.

“This is the miracle rice—IR8,” says Gregorio, as we stop beside an emerald patch of crowded, thigh-high rice plants. Roosters crow in the distance; egrets gleam white against so much green; silvery light glints off the flooded fields. IRRI, a nonprofit, was founded by the Ford and Rockefeller Foundations in 1960. Two years later a plant pathologist named Peter Jennings began a series of crossbreeding experiments. He had 10,000 varieties of rice seeds to work with. His eighth cross—between a dwarf strain from Taiwan and a taller variety from Indonesia—created the fast-growing, high-yielding strain later known as India Rice 8 for its role in preventing famine in that country. “It revolutionized rice production in Asia,” says Gregorio. “Some parents in India named their sons IR8.”

Walking along the paddies, we pass other landmark breeds, each designated with a neatly painted wooden sign. The institute releases dozens of new varieties every year; about a thousand have been planted around the world since the 1960s. Yields have typically improved by just under one percent a year. “We want to raise that to 2 percent,” Gregorio says. The world’s population growth rate, now 1.14 percent a year, is projected to slow to 0.5 percent by 2050.

When the green revolution began in the 1960s, it was before the revolution in molecular genetics: IR8, the first miracle rice, was bred without knowledge of the genes that blessed it with high yields. Breeders today can zero in on genes, but they still use traditional techniques and ever more complex pedigrees. That’s how they’ve created rice varieties adapted to rising sea levels—including Swarna-Sub1, popular in India, and IR64 Sub1, whose pedigree is shown here.

Graphic of rice pedigree

Click here to trace the pedigree.

For many decades IRRI focused on improving traditional varieties of rice, grown in fields that are flooded at planting time. Lately it has shifted its attention to climate change. It now offers drought-tolerant varieties, including one that can be planted in dry fields and subsist on rainfall, as corn and wheat do. There’s a salt-tolerant rice for countries like Bangladesh, where rising seas are poisoning rice fields. “Farmers don’t realize the salt water is coming into their fields,” says Gregorio. “By the time the water is salty enough to taste, the plants are already dying.”

Only a few of the rice varieties at IRRI are GM crops, in the sense that they contain a gene transferred from a different species, and none of those are publicly available yet. One is Golden Rice, which contains genes from corn that allow it to produce beta-carotene; its purpose is to combat the global scourge of vitamin A deficiency. Last summer an IRRI test plot of Golden Rice was trampled by anti-GM activists. IRRI creates GM varieties only as a last resort, says director Robert Zeigler, when it can’t find the desired trait in rice itself.

Yet the institute’s entire breeding operation has been accelerated by modern genetics. For decades IRRI breeders patiently followed the ancient recipe: Select plants with the desired trait, cross-pollinate, wait for the offspring to reach maturity, select the best performers, repeat. Now there’s an alternative to that painstaking process. In 2004 an international consortium of researchers mapped the entire rice genome, which comprises some 40,000 individual genes. Since then, researchers around the world have been pinpointing genes that control valuable traits and can be selected directly.

In 2006, for example, plant pathologist Pamela Ronald of the University of California, Davis, isolated a gene called Sub1 from an East Indian rice variety. Seldom grown now because of its low yields, the East Indian rice has one remarkable characteristic: It can survive for two weeks underwater. Most varieties die after three days.

Researchers at IRRI cross-pollinated Sub1 rice with a high-yielding, flavorful variety called Swarna, which is popular in India and Bangladesh. Then they screened the DNA to determine which seedlings had actually inherited the Sub1 gene. The technology, called marker-assisted breeding, is more accurate and saves time. The researchers didn’t have to plant the seedlings, grow them, and then submerge them for two weeks to see which would survive.

The new flood-tolerant rice, called Swarna-Sub1, has been planted by nearly four million farmers in Asia, where every year floods destroy about 50 million acres of rice. One recent study found that farmers in 128 villages in the Indian state of Odisha, on the Bay of Bengal, increased their yields by more than 25 percent. The most marginal farmers reaped the most benefit.

“The lowest castes in India are given the worst land, and the worst lands in Odisha are prone to flooding,” says Zeigler. “So here is a very sophisticated biotechnology—flood-tolerant rice—that preferentially benefits the poorest of the poor, the Untouchables. That’s a helluva story, I think.”

The institute’s most ambitious project would transform rice fundamentally and perhaps increase yields dramatically. Rice, wheat, and many other plants use a type of photosynthesis known as C3, for the three-carbon compound they produce when sunlight is absorbed. Corn, sugarcane, and some other plants use C4 photosynthesis. Such crops require far less water and nitrogen than C3 crops do, “and typically have 50 percent higher yields,” says William Paul Quick of IRRI. His plan is to convert rice into a C4 crop by manipulating its own genes.

C4 photosynthesis, unlike the submergence tolerance of Sub1 rice, is controlled by many genes, not just one, which makes it a challenging trait to introduce. On the other hand, says Quick, “it has evolved independently 62 times. That suggests it can’t be that difficult to do.” By “knocking out” genes one by one, he and his colleagues are systematically identifying all the genes responsible for photosynthesis in Setaria viridis, a small, fast-growing C4 grass. So far all the genes they’ve found are also present in C3 plants. They’re just not used in the same way.

Quick and his colleagues hope to learn how to switch them on in rice. “We think it will take a minimum of 15 years to do this,” Quick says. “We’re in year four.” If they succeed, the same techniques might help enhance the productivity of potatoes, wheat, and other C3 plants. It would be an unprecedented boon to food security; in theory yields could jump by 50 percent.

Prospects like that have made Zeigler a passionate advocate of biotechnology. White-bearded and avuncular, a self-described old lefty, Zeigler believes the public debate over genetically modified crops has become horribly muddled. “When I was starting out in the ’60s, a lot of us got into genetic engineering because we thought we could do a lot of good for the world,” he says. “We thought, These tools are fantastic!

“We do feel a bit betrayed by the environmental movement, I can tell you that. If you want to have a conversation about what the role of large corporations should be in our food supply, we can have that conversation—it’s really important. But it’s not the same conversation about whether we should use these tools of genetics to Excellerate our crops. They’re both important, but let’s not confound them.”

Zeigler decided on his career after a stint as a science teacher in the Peace Corps in 1972. “When I was in the Democratic Republic of the Congo, I saw a cassava famine,” he says. “That’s what made me become a plant pathologist.”

Which vision of agriculture is right for the farmers of sub-Saharan Africa? Today, says Nigel Taylor, a geneticist at the Donald Danforth Plant Science Center in St. Louis, Missouri, the brown streak virus has the potential to cause another cassava famine. “It has become an epidemic in the last five to ten years, and it’s getting worse,” he says. “With higher temperatures, the whitefly’s range is expanding. The great concern is that brown streak is starting to move into central Africa, and if it hits the massive cassava-growing areas of West Africa, you’ve got a major food-security issue.”

Taylor and other researchers are in the early stages of developing genetically modified cassava varieties that are immune to the brown streak virus. Taylor is collaborating with Ugandan researchers on a field trial, and another is under way in Kenya. But only four African countries—Egypt, Sudan, South Africa, and Burkina Faso—currently allow the commercial planting of GM crops.

In Africa, as elsewhere, people fear GM crops, even though there’s little scientific evidence to justify the fear. There’s a stronger argument that high-tech plant breeds are not a panacea and maybe not even what African farmers need most. Even in the United States some farmers are having problems with them.

A paper published last March, for instance, documented an unsettling trend: Corn rootworms are evolving resistance to the bacterial toxins in Bt corn. “I was surprised when I saw the data, because I knew what it meant—that this technology was starting to fail,” says Aaron Gassmann, an entomologist at Iowa State University and co-author of the report. One problem, he says, is that some farmers don’t follow the legal requirement to plant “refuge fields” with non-Bt corn, which slow the spread of resistant genes by supporting rootworms that remain vulnerable to the Bt toxins.

In Tanzania there are no GM crops yet. But some farmers are learning that a simple, low-tech solution—planting a diversity of crops—is one of the best ways to deter pests. Tanzania now has the fourth largest number of certified organic farmers in the world. Part of the credit belongs to a young woman named Janet Maro.

Maro grew up on a farm near Kilimanjaro, the fifth of eight children. In 2009, while still an undergraduate at the Sokoine University of Agriculture in Morogoro, she helped start a nonprofit called Sustainable Agriculture Tanzania (SAT). Since then she and her small staff have been training local farmers in organic practices. SAT now receives support from Biovision, the Swiss organization headed by Hans Herren.

Morogoro lies about a hundred miles west of Dar es Salaam, at the base of the Uluguru Mountains. A few days after my visit with Juma in Bagamoyo, Maro takes me into the mountains to visit three of the first certified organic farms in Tanzania. “Agricultural agents don’t come here,” she says as we lurch up a steep, rutted dirt road in a pickup. Greened by rains drifting in from the Indian Ocean, the slopes remain heavily forested. But increasingly they’ve been cleared for farming by the Luguru people.

Every quarter mile or so we pass women walking alone or in small groups, balancing baskets of cassavas, papayas, or bananas on their heads. It’s market day in Morogoro, 3,000 feet below us. Women here are more than porters. Among the Luguru, landownership in a family passes down the female line. “If a woman doesn’t like a man, out he goes!” Maro says.

She stops at a one-room brick house with partially plastered walls and a corrugated metal roof. Habija Kibwana, a tall woman in a short-sleeved white blouse and wraparound skirt, invites us and two neighbors to sit on her porch.

Unlike the farmers in Bagamoyo, Kibwana and her neighbors raise a variety of crops: Bananas, avocados, and passion fruit are in season now. Soon they’ll be planting carrots, spinach, and other leafy vegetables, all for local consumption. The mix provides a backup in case one crop fails; it also helps cut down on pests. The farmers here are learning to plant strategically, setting out rows of Tithonia diversifolia, a wild sunflower that whiteflies prefer, to draw the pests away from the cassavas. The use of compost instead of synthetic fertilizers has improved the soil so much that one of the farmers, Pius Paulini, has doubled his spinach production. Runoff from his fields no longer contaminates streams that supply Morogoro’s water.

Perhaps the most life-altering result of organic farming has been the liberation from debt. Even with government subsidies, it costs 500,000 Tanzanian shillings, more than $300, to buy enough fertilizer and pesticide to treat a single acre—a crippling expense in a country where the annual per capita income is less than $1,600. “Before, when we had to buy fertilizer, we had no money left over to send our children to school,” says Kibwana. Her oldest daughter has now finished high school.

And the farms are more productive too. “Most of the food in our markets is from small farmers,” says Maro. “They feed our nation.”

When I ask Maro if genetically modified seeds might also help those farmers, she’s skeptical. “It’s not realistic,” she says. How could they afford the seeds when they can’t even afford fertilizer? How likely is it, she asks, in a country where few farmers ever see a government agricultural adviser, or are even aware of the diseases threatening their crops, that they’ll get the support they need to grow GM crops properly? From Kibwana’s porch we have sweeping views of richly cultivated terraced slopes—but also of slopes scarred by the brown, eroded fields of nonorganic farmers, most of whom don’t build terraces to retain their precious soil. Kibwana and Paulini say their own success has attracted the attention of their neighbors. Organic farming is spreading here. But it’s spreading slowly.

That’s the central problem, I thought as I left Tanzania: getting knowledge that works from organizations like SAT or IRRI to people like Juma. It’s not choosing one type of knowledge—low-tech versus high-tech, organic versus GM—once and for all. There’s more than one way to increase yields or to stop a whitefly. “Organic farming can be the right approach in some areas,” says Monsanto executive Mark Edge. “By no means do we think that GM crops are the solution for all the problems in Africa.” Since the first green revolution, says Robert Zeigler, ecological science has advanced along with genetics. IRRI uses those advances too.

“You see the egrets flying out there?” he asks toward the end of our conversation. Outside his office a flock is descending on the green paddies; the mountains beyond glow with evening light. “In the early ’90s you didn’t see birds here. The pesticides we used killed the birds and snails and everything else. Then we invested a lot to understand the ecological structures of rice paddies. You have these complex webs, and if you disrupt them, you have pest outbreaks. We learned that in the vast majority of cases, you don’t need pesticides. Rice is a tough plant. You can build resistance into it. We now have a rich ecology here, and our yields haven’t dropped.

“At certain times of the day we get a hundred or so of those egrets. It’s really uplifting to see. Things can get better.”

Picture of a cross section of corn, rice, and genetically manipulated rice

Can rice be made to photosynthesize as efficiently as corn? If so, yields could rise 50 percent. In a magnified cross section of a corn leaf (left), photosynthesis proteins are stained fluorescent green. Ordinary rice (middle) makes none of the proteins—but rice that has been genetically manipulated by IRRI scientists (right) makes some. William Paul Quick, IRRI

Tim Folger’s last feature was the September 2013 cover story on sea-level rise. This is photographer Craig Cutler’s first article for the magazine.

The magazine thanks The Rockefeller Foundation and members of the National Geographic Society for their generous support of this series of articles.

Mon, 14 Aug 2023 11:35:00 -0500 text/html https://www.nationalgeographic.com/foodfeatures/green-revolution/?ref=quillette.com
Killexams : NI Announces New LabVIEW Features to Turn Test Performance into Business Performance

New User-Focused Features Include Zoom for Block Diagram

AUSTIN, Texas, July 27, 2023--(BUSINESS WIRE)--NI, formerly known as National Instruments, today announced a significant upgrade to its flagship product LabVIEW. For nearly 40 years, LabVIEW has been the industry-standard product in the field of data acquisition, instrument control and automation. These latest improvements further enable engineers in their use of test insights and data to drive product and business performance. The latest improvements include:

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20230727693038/en/

LabVIEW Featuring ZOOM

  • Zoom for Block Diagram

  • Quick change for faster object creation

  • Double-click to create control or indicator from a wire

  • Visual improvements to Highlight Execution and option for execution speeds

  • Faster re-building of applications and packed project libraries

  • Virtual environment support for Python and LabVIEW users (announced Q1 2023)

"It was exciting to see the appreciation from the audience at NI Connect when we demonstrated the upcoming, ease-of-use improvements with this new version of LabVIEW," says Eric Reffett, Director of Product Management at NI. "Additions like Zoom and quick change are meaningful in a graphical development environment, and we are energized by both the engagement we got from the community during design, as well as the impact we know it will have."

In addition, NI and JKI entered a long-term collaboration to focus on improving package-related workflows in LabVIEW. This included expanding VI Package Manager (VIPM) features, making it more robust and versatile for developers, as well as the addition of Dragon. This initial release is focused on using projects and packages, and the relationship will continue to Excellerate the way developers share and re-use code.

"I’m thrilled to work with NI," says Jim Kring, CEO of JKI. "JKI first created VIPM to help LabVIEW developers build and reuse LabVIEW code libraries, and it has since helped developers for over a decade. This collaboration with NI expands both the functionality available to all LabVIEW developers in VIPM, as well as the access developers have to resources available in VIPM.io, but this initiative is just the beginning."

The new LabVIEW features have made it more user-friendly, efficient and powerful for helping test professionals and engineers focus on turning test performance into business performance. For more information, visit NI’s LabVIEW page:

https://www.ni.com/en-us/support/downloads/software-products/download.labview.html

About NI

At NI, we bring together the people, ideas and technology so forward thinkers and creative problem solvers can take on humanity’s biggest challenges. From data and automation to research and validation, we provide the tailored, software-connected systems engineers and enterprises need to Engineer Ambitiously™ every day.

National Instruments, NI, ni.com, LabVIEW and Engineer Ambitiously are trademarks of National Instruments Corporation. Other product and company names listed are trademarks or trade names of their respective companies.

View source version on businesswire.com: https://www.businesswire.com/news/home/20230727693038/en/

Contacts

NI Corporate Media Relations
Email: pr@ni.com

Thu, 27 Jul 2023 01:03:00 -0500 en-US text/html https://finance.yahoo.com/news/ni-announces-labview-features-turn-110000034.html
Killexams : NI Announces New LabVIEW Features to Turn Test Performance into Business Performance

New User-Focused Features Include Zoom for Block Diagram

NI, formerly known as National Instruments, today announced a significant upgrade to its flagship product LabVIEW. For nearly 40 years, LabVIEW has been the industry-standard product in the field of data acquisition, instrument control and automation. These latest improvements further enable engineers in their use of test insights and data to drive product and business performance. The latest improvements include:

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20230727693038/en/

LabVIEW Featuring ZOOM

LabVIEW Featuring ZOOM

  • Zoom for Block Diagram
  • Quick change for faster object creation
  • Double-click to create control or indicator from a wire
  • Visual improvements to Highlight Execution and option for execution speeds
  • Faster re-building of applications and packed project libraries
  • Virtual environment support for Python and LabVIEW users (announced Q1 2023)

“It was exciting to see the appreciation from the audience at NI Connect when we demonstrated the upcoming, ease-of-use improvements with this new version of LabVIEW,” says Eric Reffett, Director of Product Management at NI. “Additions like Zoom and quick change are meaningful in a graphical development environment, and we are energized by both the engagement we got from the community during design, as well as the impact we know it will have.”

In addition, NI and JKI entered a long-term collaboration to focus on improving package-related workflows in LabVIEW. This included expanding VI Package Manager (VIPM) features, making it more robust and versatile for developers, as well as the addition of Dragon. This initial release is focused on using projects and packages, and the relationship will continue to Excellerate the way developers share and re-use code.

“I’m thrilled to work with NI,” says Jim Kring, CEO of JKI. “JKI first created VIPM to help LabVIEW developers build and reuse LabVIEW code libraries, and it has since helped developers for over a decade. This collaboration with NI expands both the functionality available to all LabVIEW developers in VIPM, as well as the access developers have to resources available in VIPM.io, but this initiative is just the beginning.”

The new LabVIEW features have made it more user-friendly, efficient and powerful for helping test professionals and engineers focus on turning test performance into business performance. For more information, visit NI’s LabVIEW page:

https://www.ni.com/en-us/support/downloads/software-products/download.labview.html

About NI

At NI, we bring together the people, ideas and technology so forward thinkers and creative problem solvers can take on humanity’s biggest challenges. From data and automation to research and validation, we provide the tailored, software-connected systems engineers and enterprises need to Engineer Ambitiously™ every day.

National Instruments, NI, ni.com, LabVIEW and Engineer Ambitiously are trademarks of National Instruments Corporation. Other product and company names listed are trademarks or trade names of their respective companies.

Wed, 26 Jul 2023 23:58:00 -0500 text/html https://stockhouse.com/news/press-releases/2023/07/27/ni-announces-new-labview-features-to-turn-test-performance-into-business
CLAD exam dump and training guide direct download
Training Exams List